Epstein-Barr virus nuclear antigen 1 (EBNA1) induced cytotoxicity in epithelial cells is associated with EBNA1 degradation and processing

Virology

Volumn 313, Issue 2, 2003, Pages 663-676

  Jones, Richard J ^a   Smith, Laura J ^a   Dawson, Christopher W ^a   Haigh, Tracy ^a   Blake, Neil W ^b   Young, Lawrence S ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN; PROTEIN BCL 2;

ARTICLE; CELL GROWTH; CELL LINE; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; EPITHELIUM CELL; EPSTEIN BARR VIRUS; GROWTH INHIBITION; HELA CELL; HUMAN; HUMAN CELL; MOLECULAR RECOGNITION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROCESSING; SEQUENCE HOMOLOGY; SQUAMOUS EPITHELIUM; VIRUS INFECTION; VIRUS RECOMBINANT;

HUMAN HERPESVIRUS 4;

EID: 0042887514     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0042-6822(03)00392-1     Document Type: Article

References (36)

1. Babcock G.J., Decker L.L., Volk M., Thorley-Lawson D.A. EBV persistence in memory B cells in vivo. Immunity. 9:1998;395-404.
2. Blake N., Haigh T., Shaka'a G., Croom-Carter D., Rickinson A.B. The importance of exogenous antigen in priming the human CD8+ T cell response lessons from the EBV nuclear antigen EBNA1 . J. Immunol. 165:2000;7078-7087.
3. Blake N., Lee S., Redchenko I., Thomas W., Steven N., Leese A., Steigerwald-Mullen P., Kurilla M.G., Frappier L., Rickinson A.B. Human CD8+ T cell responses to EBV EBNA1 HLA class I presentation of the (Gly-Ala) -containing protein requires exogenous processing . Immunity. 7:1997;791-802.
4. Borza C.M., Hutt-Fletcher L.M. Epstein-Barr virus recombinant lacking expression of glycoprotein gp150 infects B cells normally but is enhanced for infection of epithelial cells. J. Virol. 72:1998;7577-7582.
5. Dawson C.W., Dawson J., Jones R., Ward K., Young L.S. Functional differences between BHRF1, the EBV-encoded Bcl-2 homologue, and bcl-2 in human epithelial cells. J. Virol. 72:1998;9016-9024.
6. Dawson C.W., Eliopoulos A.G., Dawson J., Young L.S. BHRF1, a viral homologue of the Bcl-2 oncogene, disturbs epithelial cell differentiation. Oncogene. 9:1995;69-77.
7. Dawson C.W., Rickinson A.B., Young L.S. Epstein-Barr virus latent membrane protein inhibits human epithelial cell differentiation. Nature. 344:1990;777-780.
8. Friborg J., Kong W.P., Hottinger M.O., Nabel G.J. p53 inhibition by the LANA protein of KSHV protects against cell death. Nature. 402:1999;889-894.
9. Glaser R., Lang C.M., Rapp F. Rescue of Epstein-Barr virus from somatic cell hybrids of Burkitt lymphoblastoid cells. J. Virology. 10:1972;288-296.
10. Greenspan J.S., Greenspan D., Lennette E.T., Abrams D.I., Canant M.A., Petersen V., Freese U.K. Replication of Epstein-Barr virus within the epithelial cells of oral hairy leukoplakia, an AIDS-associated lesion. New Engl. J. Med. 313:1985;1564-1571.
11. Hershko A., Ciechanover A. The ubiquitin system. Ann. Rev. Biochem. 67:1998;425-479.
12. Imai S., Koizumi S., Sugiura M., Tokunaga M., Uemura Y., Yamamoto N., Tanaka S., Sata E., Osato T. Gastric carcinoma Monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein . Proc. Natl. Acad. Sci. USA. 91:1994;9131-9135.
13. Imai S., Nishikawa J., Takada K. Cell-to-cell contact as an efficient mode of Epstein-Barr Virus infection of diverse human epithelial cells. J. Virol. 72:1998;4371-4378.
14. Knox P.G., Li Q.X., Rickinson A.B., Young L.S. In vitro production of stable Epstein-Barr virus-positive epithelial cell clones which resemble the virus cell interaction observed in nasopharyngeal carcinoma . Virology. 215:1996;40-50.
15. Lee M.A., Diamond M.E., Yates J.L. Genetic evidence that EBNA-1 is needed for efficient, stable latent infection by Epstein-Barr virus. J. Virol. 73:1999;2974-2982.
16. Levitskaya J., Coram M., Levitsky V., Imreh S., Steigerwald-Mullen P.M., Masucci M.G. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Nature. 375:1995;685-688.
17. Levitskaya J., Sharipo A., Leonchiks A., Ciechanover A., Masucci M.G. Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1. Proc. Natl. Acad. Sci. USA. 94:1997;12616-12621.
18. Li Q.X., Young L.S., Niedobitek G., Dawson C.W., Birkenbach M., Wang F., Rickinson A.B. Epstein-Barr virus infection and replication in a human epithelial cell system. Nature. 356:1992;347-350.
19. Marechal V., Dehee A., Chikhi-Brachet R., Piolot T., Coppey-Moisan M., Nicholas J.C. Mapping EBNA-1 domains involved in binding to metaphase chromosomes. J. Virol. 73:1999;4385-4392.
20. Munz C., Bickham K.L., Subklewe M., Tsang M.L., Chahroudi A., Kurilla M.G., Zhang D., O'Donnell M., Steinman R.M. Human CD4+ T lymphocytes consistently respond to the latent Epstein-Barr virus nuclear antigen EBNA1. Exp. Med. 191:2000;1649-1660.
21. Murray P.G., Niedobitek G., Kremmer E., Grasser F., Reynolds G.M., Cruchley A., Williams D.M., Muller-Lantzsch N., Young L.S. In situ detection of the Epstein-Barr virus-encoded nuclear antigen 1 in oral hairy leukoplakia and virus-associated carcinomas. J. Pathol. 178:1996;44-47.
22. Murray P.G., Young L.S. The role of the Epstein-Barr virus in human disease. Front. Biosci. 7:2002;519-540.
23. Niedobitek G., Young L.S. Epstein-Barr virus persistence and virus-associated tumours. Lancet. 343:1994;333-335.
24. Parkinson E.K., Grabham P., Emmerson A. A subpopulation of cultured human keratinocytes which is resistant to the induction of terminal differentiation-related changes by phorbol, 12-myristate, 13-acetate evidence for an increase in the resistant population following transformation . Carcinogenesis. 4:1983;857-861.
25. Pathmanathan R., Prasad U., Sadler R., Flynn K., Raab-Traub N. Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. New Engl. J. Med. 333:1995;693-698.
26. Radkov S.A., Kellam P., Boshoff C. The latent nuclear antigen of Kaposi's sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene HRAS transforms primary rat cells. Nat. Med. 6:2000;1121-1127.
27. Rickinson A.B., Kieff E. Epstein-Barr virus. Knipe D.M., Howley P.M. Fields Virology. 2001;2575-2627 Lippincott/Williams & Wilkins, Philadelphia, PA.
28. Sheu L.F., Meng C.L., Ho K.C., Lee W.H., Leu F.J., Chao C.F. Enhanced malignant progression of nasopharyngeal carcinoma cells mediated by the expression of Epstein-Barr nuclear antigen 1 in vivo. J. Pathol. 180:1996;243-248.
29. Schlager S., Speck S.H., Woisetschlager M. Transcription of the Epstein-Barr virus nuclear antigen 1 (EBNA1) gene occurs before induction of the BCR2 (Cp) EBNA gene promoter during the initial stages of infection in B cells. J. Virol. 70:1996;3561-3570.
30. Steven N.M., Annels N.E., Kumar A., Leese A.M., Kurilla M.G., Rickinson A.B. Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response. J. Exp. Med. 185:1997;1605-1617.
31. Takimoto T., Ogura H., Sato H., Umeda R., Hatano M. Isolation of transforming and early antigen-inducing Epstein-Barr virus from nasopharyngeal carcinoma hybrid cells (NPC-KT). J. Natl. Cancer Inst. 74:1985;57-59.
32. Thomas J.T., Hubert W.G., Ruesch M.N., Laimins L.A. Human papillomavirus type 31 oncoproteins E6 and E7 are required for the maintenance of episomes during the viral life cycle in normal human keratinocytes. Proc. Natl. Acad. Sci. USA. 96:1999;8449-8454.
33. Vidal M., Wrighton C., Eccles S., Burke J., Grosveld G. Differences in human cell lines to support stable replication of Epstein-Barr virus-based vectors. Biochem. Biophys. Acta. 1048:1990;171-177.
34. Wilson J.B., Bell J.L., Levine A.J. Expression of Epstein-Barr virus nuclear antigen-1 induces B cell neoplasia in trangenic mice. EMBO J. 15:1996;3117-3126.
35. Yates J., Warren N., Reisman D., Sugden B. A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells. Proc. Natl. Acad. Sci. USA. 81:1984;3806-3810.
36. Young L.S. Epstein-Barr virus infection and persistence a B-cell marriage in sickness and in health . Lancet. 354:1999;1141-1142.